Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with higher baseline serum levels of immunoglobulin E and thymus and activation-regulated chemokine but not clinical severity in a real-world setting
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference5 articles.
1. Conjunctivitis in dupilumab clinical trials;Akinlade;Br J Dermatol,2019
2. Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study;Uchida;Br J Dermatol,2019
3. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis;Beck;N Engl J Med,2014
4. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis;Hamilton;J Allergy Clin Immunol,2014
5. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis;Guttman-Yassky;J Allergy Clin Immunol,2019
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Okuläre Nebenwirkungen von Dupilumab – Übersichtsarbeit und Therapieempfehlung der „Kommission für Trockenes Auge und Oberflächenerkrankungen“ der Österreichischen Ophthalmologischen Gesellschaft (ÖOG);Spektrum der Augenheilkunde;2023-09-12
2. Ocular side effects of dupilumab-Review article and treatment recommendation by the Committee for Dry Eye and Ocular Surface Diseases of the Austrian Society of Ophthalmology (?OG);SPEKTRUM AUGENHEILKD;2023
3. Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review;Journal of the American Academy of Dermatology;2023-08
4. Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions;Current Opinion in Allergy & Clinical Immunology;2023-07-28
5. Optimal Use of Jak Inhibitors and Biologics for Atopic Dermatitis on the Basis of the Current Evidence;JID Innovations;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3